J&J and Bayer Launch New Xarelto Study

Johnson & Johnson and Bayer are reportedly seeking additional Food and Drug Administration (FDA) approval for Xarelto, the companies’ lucrative blood thinner that many lawsuits claim can cause injuries and death from uncontrollable bleeding.

As Xarelto Lawsuits Are Consolidated in Louisiana and Philadelphia, Drug Makers Seek Additional FDA Approval to Prescribe Blood Thinner for Stroke Victims

Xarelto is one of several new prescription anticoagulants known as Factor Xa inhibitors. In 2014, the pharmaceutical brought in $1.5 billion in sales. Looking for even more profits, Xarelto’s makers are now asking for the FDA’s approval to allow the drug to be prescribed for stroke patients. The new NAVIGATE-ESUS clinical trial involves 7,000 patients and will study whether Xarelto is more effective than aspirin in preventing subsequent strokes. If the trial goes well for Johnson & Johnson and Bayer, Xarelto could be prescribed for an additional 300,000 people who suffer strokes each year in North America and Europe.

Many prescription drugs that patients believe to be safe can cause severe illness and death.

Although the Xarelto business appears to be booming for its manufacturers, some of the drug’s users have had a less favorable experience. Xarelto lawsuits around the country allege that one of the drug’s major drawbacks is its potential to cause uncontrollable bleeding. Unlike warfarin, which many Xarelto users took before they switched to Xarelto, there is no antidote to the drug that can stop bleeding once it begins.

So many Xarelto injury lawsuits have been filed that the suits have been consolidated in Philadelphia and Louisiana. The lawsuits allege that the pharmaceutical makers failed to adequately warn that Xarelto use carries an increased risk for severe bleeding incidents.

Contact Waters Kraus & Paul to Learn More About Filing a Xarelto Lawsuit

If you have suffered injuries or the death of a loved one associated with Xarelto,contact us by email or call our Xarelto lawyers at 800.226.9880 to learn more about how we can assist you with a Xarelto lawsuit.

What are my chances?

That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus & Paul has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.

Call 800.226.9880